Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1033 to 1034 of 1034 entries
Sorted by: Best Match Show Resources per page
Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study.

Journal of clinical medicine

Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M.
PMID: 34884399
J Clin Med. 2021 Dec 03;10(23). doi: 10.3390/jcm10235698.

Gut microbiome and colonic inflammation can be associated with the predisposition and progression of Parkinson's disease (PD). The presented study aimed to compare gastrointestinal microbiota composition between patients diagnosed with PD and treated only with Levodopa to healthy controls....

Cite
Zapała B, Stefura T, Wójcik-Pędziwiatr M, et al. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235698.
Zapała, B., Stefura, T., Wójcik-Pędziwiatr, M., Kabut, R., Bałajewicz-Nowak, M., Milewicz, T., Dudek, A., Stój, A., & Rudzińska-Bar, M. (2021). Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235698
Zapała, Barbara, et al. "Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235698
Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M. Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study. J Clin Med. 2021 Dec 03;10(23). doi: 10.3390/jcm10235698. PMID: 34884399.
Copy Download .nbib Format: NLM
Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome.

Molecules (Basel, Switzerland)

Świądro M, Ordon K, Herman M, Dudek D, Wietecha-Posłuszny R.
PMID: 35011323
Molecules. 2021 Dec 24;27(1). doi: 10.3390/molecules27010091.

The diagnosis of affective disorders has been the subject of constant research by clinicians from all over the world for many years. Making an appropriate diagnosis among patients suffering from mood disorders is sometimes problematic due to the personality-changing...

Cite
Świądro M, Ordon K, Herman M, et al. Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome. Molecules. 2021;27(1)doi: 10.3390/molecules27010091.
Świądro, M., Ordon, K., Herman, M., Dudek, D., & Wietecha-Posłuszny, R. (2021). Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome. Molecules (Basel, Switzerland), 27(1), . https://doi.org/10.3390/molecules27010091
Świądro, Magdalena, et al. "Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome." Molecules (Basel, Switzerland) vol. 27,1 (2021). doi: https://doi.org/10.3390/molecules27010091
Świądro M, Ordon K, Herman M, Dudek D, Wietecha-Posłuszny R. Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome. Molecules. 2021 Dec 24;27(1). doi: 10.3390/molecules27010091. PMID: 35011323; PMCID: PMC8746725.
Copy Download .nbib Format: NLM
Showing 1033 to 1034 of 1034 entries